Logo image of BOI.PA

BOIRON SA (BOI.PA) Stock Fundamental Analysis

Europe - Euronext Paris - EPA:BOI - FR0000061129 - Common Stock

28.5 EUR
+0.05 (+0.18%)
Last: 11/28/2025, 7:00:00 PM
Fundamental Rating

5

BOI gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 55 industry peers in the Pharmaceuticals industry. BOI is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. BOI has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year BOI was profitable.
In the past year BOI had a positive cash flow from operations.
Each year in the past 5 years BOI has been profitable.
Each year in the past 5 years BOI had a positive operating cash flow.
BOI.PA Yearly Net Income VS EBIT VS OCF VS FCFBOI.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

1.2 Ratios

With a Return On Assets value of 3.45%, BOI perfoms like the industry average, outperforming 41.82% of the companies in the same industry.
BOI has a Return On Equity of 5.25%. This is comparable to the rest of the industry: BOI outperforms 43.64% of its industry peers.
BOI has a Return On Invested Capital of 4.43%. This is comparable to the rest of the industry: BOI outperforms 41.82% of its industry peers.
BOI had an Average Return On Invested Capital over the past 3 years of 5.61%. This is significantly below the industry average of 14.90%.
Industry RankSector Rank
ROA 3.45%
ROE 5.25%
ROIC 4.43%
ROA(3y)4.57%
ROA(5y)4.15%
ROE(3y)6.7%
ROE(5y)6.13%
ROIC(3y)5.61%
ROIC(5y)5.46%
BOI.PA Yearly ROA, ROE, ROICBOI.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

BOI has a Profit Margin (3.84%) which is comparable to the rest of the industry.
BOI's Profit Margin has declined in the last couple of years.
Looking at the Operating Margin, with a value of 5.26%, BOI is doing worse than 60.00% of the companies in the same industry.
BOI's Operating Margin has declined in the last couple of years.
With a decent Gross Margin value of 73.71%, BOI is doing good in the industry, outperforming 63.64% of the companies in the same industry.
In the last couple of years the Gross Margin of BOI has remained more or less at the same level.
Industry RankSector Rank
OM 5.26%
PM (TTM) 3.84%
GM 73.71%
OM growth 3Y-32.06%
OM growth 5Y-23.58%
PM growth 3Y-28.17%
PM growth 5Y-20.44%
GM growth 3Y0.74%
GM growth 5Y-0.95%
BOI.PA Yearly Profit, Operating, Gross MarginsBOI.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60 80

7

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), BOI is destroying value.
Compared to 1 year ago, BOI has about the same amount of shares outstanding.
Compared to 5 years ago, BOI has less shares outstanding
BOI has a worse debt/assets ratio than last year.
BOI.PA Yearly Shares OutstandingBOI.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
BOI.PA Yearly Total Debt VS Total AssetsBOI.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

BOI has an Altman-Z score of 3.68. This indicates that BOI is financially healthy and has little risk of bankruptcy at the moment.
BOI's Altman-Z score of 3.68 is in line compared to the rest of the industry. BOI outperforms 54.55% of its industry peers.
BOI has a debt to FCF ratio of 0.49. This is a very positive value and a sign of high solvency as it would only need 0.49 years to pay back of all of its debts.
BOI's Debt to FCF ratio of 0.49 is amongst the best of the industry. BOI outperforms 96.36% of its industry peers.
BOI has a Debt/Equity ratio of 0.04. This is a healthy value indicating a solid balance between debt and equity.
BOI's Debt to Equity ratio of 0.04 is amongst the best of the industry. BOI outperforms 89.09% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF 0.49
Altman-Z 3.68
ROIC/WACC0.55
WACC8.01%
BOI.PA Yearly LT Debt VS Equity VS FCFBOI.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

2.3 Liquidity

BOI has a Current Ratio of 2.39. This indicates that BOI is financially healthy and has no problem in meeting its short term obligations.
With a decent Current ratio value of 2.39, BOI is doing good in the industry, outperforming 78.18% of the companies in the same industry.
BOI has a Quick Ratio of 1.46. This is a normal value and indicates that BOI is financially healthy and should not expect problems in meeting its short term obligations.
With a decent Quick ratio value of 1.46, BOI is doing good in the industry, outperforming 78.18% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.39
Quick Ratio 1.46
BOI.PA Yearly Current Assets VS Current LiabilitesBOI.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

3

3. Growth

3.1 Past

BOI shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -18.25%.
Measured over the past years, BOI shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -22.40% on average per year.
Looking at the last year, BOI shows a small growth in Revenue. The Revenue has grown by 4.80% in the last year.
Measured over the past years, BOI shows a decrease in Revenue. The Revenue has been decreasing by -2.63% on average per year.
EPS 1Y (TTM)-18.25%
EPS 3Y-26.29%
EPS 5Y-22.4%
EPS Q2Q%241.06%
Revenue 1Y (TTM)4.8%
Revenue growth 3Y2.32%
Revenue growth 5Y-2.63%
Sales Q2Q%7.58%

3.2 Future

BOI is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 2.73% yearly.
The Revenue is expected to grow by 5.54% on average over the next years.
EPS Next Y5.53%
EPS Next 2Y2.73%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year2.95%
Revenue Next 2Y1.47%
Revenue Next 3Y8.32%
Revenue Next 5Y5.54%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
BOI.PA Yearly Revenue VS EstimatesBOI.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 200M 400M 600M
BOI.PA Yearly EPS VS EstimatesBOI.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 1 2 3 4

4

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 25.45, the valuation of BOI can be described as expensive.
The rest of the industry has a similar Price/Earnings ratio as BOI.
When comparing the Price/Earnings ratio of BOI to the average of the S&P500 Index (26.31), we can say BOI is valued inline with the index average.
A Price/Forward Earnings ratio of 12.32 indicates a correct valuation of BOI.
BOI's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. BOI is cheaper than 69.09% of the companies in the same industry.
BOI is valuated cheaply when we compare the Price/Forward Earnings ratio to 36.59, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 25.45
Fwd PE 12.32
BOI.PA Price Earnings VS Forward Price EarningsBOI.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of BOI indicates a rather cheap valuation: BOI is cheaper than 92.73% of the companies listed in the same industry.
BOI's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. BOI is cheaper than 78.18% of the companies in the same industry.
Industry RankSector Rank
P/FCF 13.41
EV/EBITDA 6.19
BOI.PA Per share dataBOI.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20 25

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates BOI does not grow enough to justify the current Price/Earnings ratio.
PEG (NY)4.6
PEG (5Y)N/A
EPS Next 2Y2.73%
EPS Next 3YN/A

5

5. Dividend

5.1 Amount

BOI has a Yearly Dividend Yield of 4.22%, which is a nice return.
BOI's Dividend Yield is rather good when compared to the industry average which is at 2.86. BOI pays more dividend than 81.82% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.34, BOI pays a better dividend.
Industry RankSector Rank
Dividend Yield 4.22%

5.2 History

The dividend of BOI decreases each year by -1.41%.
Dividend Growth(5Y)-1.41%
Div Incr Years0
Div Non Decr Years0
BOI.PA Yearly Dividends per shareBOI.PA Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 2 4 6 8 10

5.3 Sustainability

BOI pays out 107.57% of its income as dividend. This is not a sustainable payout ratio.
DP107.57%
EPS Next 2Y2.73%
EPS Next 3YN/A
BOI.PA Yearly Income VS Free CF VS DividendBOI.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
BOI.PA Dividend Payout.BOI.PA Dividend Payout, showing the Payout Ratio.BOI.PA Dividend Payout.PayoutRetained Earnings

BOIRON SA

EPA:BOI (11/28/2025, 7:00:00 PM)

28.5

+0.05 (+0.18%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)11-06 2025-11-06
Earnings (Next)N/A N/A
Inst Owners6.02%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap500.18M
Revenue(TTM)504.86M
Net Income(TTM)19.37M
Analysts80
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 4.22%
Yearly Dividend1.35
Dividend Growth(5Y)-1.41%
DP107.57%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 25.45
Fwd PE 12.32
P/S 0.99
P/FCF 13.41
P/OCF 9.45
P/B 1.36
P/tB 2
EV/EBITDA 6.19
EPS(TTM)1.12
EY3.93%
EPS(NY)2.31
Fwd EY8.12%
FCF(TTM)2.12
FCFY7.45%
OCF(TTM)3.02
OCFY10.58%
SpS28.77
BVpS21.03
TBVpS14.24
PEG (NY)4.6
PEG (5Y)N/A
Graham Number23.02
Profitability
Industry RankSector Rank
ROA 3.45%
ROE 5.25%
ROCE 5.9%
ROIC 4.43%
ROICexc 5.25%
ROICexgc 7.65%
OM 5.26%
PM (TTM) 3.84%
GM 73.71%
FCFM 7.39%
ROA(3y)4.57%
ROA(5y)4.15%
ROE(3y)6.7%
ROE(5y)6.13%
ROIC(3y)5.61%
ROIC(5y)5.46%
ROICexc(3y)8.01%
ROICexc(5y)8.34%
ROICexgc(3y)11.86%
ROICexgc(5y)12.41%
ROCE(3y)7.49%
ROCE(5y)7.29%
ROICexgc growth 3Y-33.41%
ROICexgc growth 5Y-24.37%
ROICexc growth 3Y-32.4%
ROICexc growth 5Y-24.82%
OM growth 3Y-32.06%
OM growth 5Y-23.58%
PM growth 3Y-28.17%
PM growth 5Y-20.44%
GM growth 3Y0.74%
GM growth 5Y-0.95%
F-Score7
Asset Turnover0.9
Health
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF 0.49
Debt/EBITDA 0.2
Cap/Depr 35.13%
Cap/Sales 3.1%
Interest Coverage 30.02
Cash Conversion 74.49%
Profit Quality 192.52%
Current Ratio 2.39
Quick Ratio 1.46
Altman-Z 3.68
F-Score7
WACC8.01%
ROIC/WACC0.55
Cap/Depr(3y)71.98%
Cap/Depr(5y)71.7%
Cap/Sales(3y)3.47%
Cap/Sales(5y)3.78%
Profit Quality(3y)124.88%
Profit Quality(5y)120.26%
High Growth Momentum
Growth
EPS 1Y (TTM)-18.25%
EPS 3Y-26.29%
EPS 5Y-22.4%
EPS Q2Q%241.06%
EPS Next Y5.53%
EPS Next 2Y2.73%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)4.8%
Revenue growth 3Y2.32%
Revenue growth 5Y-2.63%
Sales Q2Q%7.58%
Revenue Next Year2.95%
Revenue Next 2Y1.47%
Revenue Next 3Y8.32%
Revenue Next 5Y5.54%
EBIT growth 1Y-9.69%
EBIT growth 3Y-30.48%
EBIT growth 5Y-25.59%
EBIT Next Year86.05%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y108.9%
FCF growth 3Y22.31%
FCF growth 5Y12.1%
OCF growth 1Y55.98%
OCF growth 3Y5.87%
OCF growth 5Y-4.91%

BOIRON SA / BOI.PA FAQ

Can you provide the ChartMill fundamental rating for BOIRON SA?

ChartMill assigns a fundamental rating of 5 / 10 to BOI.PA.


Can you provide the valuation status for BOIRON SA?

ChartMill assigns a valuation rating of 4 / 10 to BOIRON SA (BOI.PA). This can be considered as Fairly Valued.


How profitable is BOIRON SA (BOI.PA) stock?

BOIRON SA (BOI.PA) has a profitability rating of 4 / 10.


What are the PE and PB ratios of BOIRON SA (BOI.PA) stock?

The Price/Earnings (PE) ratio for BOIRON SA (BOI.PA) is 25.45 and the Price/Book (PB) ratio is 1.36.


How sustainable is the dividend of BOIRON SA (BOI.PA) stock?

The dividend rating of BOIRON SA (BOI.PA) is 5 / 10 and the dividend payout ratio is 107.57%.